.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Cantor Fitzgerald
Novartis
Boehringer Ingelheim
Healthtrust
Mallinckrodt
Cipla
Baxter
UBS

Generated: September 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 089454

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDACardinal Health55154-9391-55 VIAL, SINGLE-DOSE in 1 BAG (55154-9391-5) > 5 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-9425 VIAL, SINGLE-DOSE in 1 TRAY (63323-229-94) > 5 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-951 VIAL, SINGLE-DOSE in 1 BOX (63323-229-95) > 25 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-1525 VIAL, SINGLE-DOSE in 1 TRAY (63323-229-15) > 5 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-2610 VIAL, SINGLE-DOSE in 1 TRAY (63323-229-26) > 25 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-351 VIAL, SINGLE-DOSE in 1 BOX (63323-229-35) > 25 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-0525 VIAL, SINGLE-DOSE in 1 TRAY (63323-229-05) > 5 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-2510 VIAL, SINGLE-DOSE in 1 TRAY (63323-229-25) > 25 mL in 1 VIAL, SINGLE-DOSE
Fresenius Kabi Usa
PROTAMINE SULFATE
protamine sulfate
INJECTABLE;INJECTION089454ANDAFresenius Kabi USA, LLC63323-229-301 VIAL, SINGLE-DOSE in 1 BOX (63323-229-30) > 25 mL in 1 VIAL, SINGLE-DOSE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Teva
Healthtrust
Merck
Mallinckrodt
Deloitte
Covington
Baxter
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot